HLA and smoking in prediction and prognosis of small cell lung cancer in autoimmune Lambert–Eaton myasthenic syndrome

This publication has 25 references indexed in Scilit:

• High innate production of interleukin-10 and tumor necrosis factor-α contributes to susceptibility for non-paraneoplastic Lambert–Eaton myasthenic syndrome
  Journal of Neuroimmunology, 2003
• Cancer immunoediting: from immunosurveillance to tumor escape
  Nature Immunology, 2002
• A genetically determined high setting of TNF-α influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity
  Human Immunology, 2001
• Increased frequency of HLA class II alleles DRB1∗0301 and DQB1∗0201 in Lambert-Eaton myasthenic syndrome without associated cancer
  Human Immunology, 2000
• Correlation of Thymic Pathology with HLA in Myasthenia Gravis
  Clinical Immunology, 1999
• The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
  Immunological Reviews, 1999
• HLA gene and haplotype frequencies in Dutch blood donors
  Tissue Antigens, 1996
• T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
  The Journal of Experimental Medicine, 1995
• Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients.
  Journal of Neurology, Neurosurgery & Psychiatry, 1991
• Increased frequency of IgG heavy chain marker Glm(2) and HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma
  Human Immunology, 1985